UroGen Pharma Ltd. (URGN)
USD 11.51
(0.88%)
USD 11.51
(0.88%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 243.52 Million USD | 8.24% |
| 2022 | 224.98 Million USD | 102.08% |
| 2021 | 111.33 Million USD | 334.05% |
| 2020 | 25.65 Million USD | 16.14% |
| 2019 | 22.08 Million USD | 64.03% |
| 2018 | 13.46 Million USD | 91.4% |
| 2017 | 7.03 Million USD | 4.24% |
| 2016 | 6.74 Million USD | 117.08% |
| 2015 | 3.1 Million USD | 248.93% |
| 2014 | 891 Thousand USD | 84.09% |
| 2013 | 484 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 276.42 Million USD | 9.9% |
| 2024 Q2 | 251.53 Million USD | 4.5% |
| 2024 Q1 | 240.7 Million USD | -1.16% |
| 2023 Q2 | 233.79 Million USD | 1.87% |
| 2023 Q3 | 235.62 Million USD | 0.78% |
| 2023 Q1 | 229.5 Million USD | 2.01% |
| 2023 FY | 243.52 Million USD | 8.24% |
| 2023 Q4 | 243.52 Million USD | 3.35% |
| 2022 Q2 | 187.05 Million USD | 2.33% |
| 2022 Q4 | 224.98 Million USD | 17.32% |
| 2022 FY | 224.98 Million USD | 102.08% |
| 2022 Q1 | 182.78 Million USD | 64.18% |
| 2022 Q3 | 191.75 Million USD | 2.52% |
| 2021 Q2 | 97.49 Million USD | 365.98% |
| 2021 Q1 | 20.92 Million USD | -18.43% |
| 2021 Q4 | 111.33 Million USD | 8.02% |
| 2021 FY | 111.33 Million USD | 334.05% |
| 2021 Q3 | 103.06 Million USD | 5.71% |
| 2020 Q4 | 25.65 Million USD | 32.45% |
| 2020 Q2 | 18.41 Million USD | 11.79% |
| 2020 FY | 25.65 Million USD | 16.14% |
| 2020 Q1 | 16.47 Million USD | -25.41% |
| 2020 Q3 | 19.36 Million USD | 5.15% |
| 2019 Q4 | 22.08 Million USD | 39.46% |
| 2019 FY | 22.08 Million USD | 64.03% |
| 2019 Q1 | 12.46 Million USD | -7.46% |
| 2019 Q3 | 15.83 Million USD | 14.87% |
| 2019 Q2 | 13.78 Million USD | 10.64% |
| 2018 Q3 | 8.97 Million USD | 12.86% |
| 2018 Q4 | 13.46 Million USD | 50.03% |
| 2018 FY | 13.46 Million USD | 91.4% |
| 2018 Q1 | 5.53 Million USD | -21.32% |
| 2018 Q2 | 7.95 Million USD | 43.67% |
| 2017 Q3 | 4.92 Million USD | -0.79% |
| 2017 Q4 | 7.03 Million USD | 42.78% |
| 2017 FY | 7.03 Million USD | 4.24% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q2 | 4.96 Million USD | 0.0% |
| 2016 Q1 | 3.49 Million USD | 56.33% |
| 2016 Q4 | 6.74 Million USD | 70.34% |
| 2016 Q3 | 3.96 Million USD | 0.0% |
| 2016 FY | 6.74 Million USD | 117.08% |
| 2016 Q2 | - USD | -100.0% |
| 2015 Q4 | 2.23 Million USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2015 FY | 3.1 Million USD | 248.93% |
| 2014 FY | 891 Thousand USD | 84.09% |
| 2014 Q4 | 891 Thousand USD | 0.0% |
| 2013 FY | 484 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -195.419% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -762.761% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1397.405% |
| Autolus Therapeutics plc | 263.9 Million USD | 7.724% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -82616.725% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -3509.352% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1538.892% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -4896.368% |
| CervoMed Inc. | 2.59 Million USD | -9281.615% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -230.125% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -592.277% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1440.436% |
| Precision BioSciences, Inc. | 140.92 Million USD | -72.809% |
| Dyadic International, Inc. | 2.34 Million USD | -10304.071% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -100.791% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -5792.161% |
| Nektar Therapeutics | 267.04 Million USD | 8.809% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | 3.593% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -2620.927% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -174.049% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -1819.923% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 30.985% |
| GRI Bio, Inc. | 2.69 Million USD | -8929.403% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -29979.979% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -683.259% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -4722.238% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -1911.805% |
| IGM Biosciences, Inc. | 220.17 Million USD | -10.603% |
| INmune Bio, Inc. | 18.86 Million USD | -1191.077% |
| Opthea Limited | 264.6 Million USD | 7.966% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -316.599% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -66.398% |
| Verastem, Inc. | 71.18 Million USD | -242.099% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -395.207% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -531.248% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -397.676% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -86.312% |
| NextCure, Inc. | 14.99 Million USD | -1523.811% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -6801.161% |
| Organovo Holdings, Inc. | 2.74 Million USD | -8761.827% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -77490.184% |
| Arvinas, Inc. | 644.6 Million USD | 62.221% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -333.085% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -376.534% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -649.925% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -92.167% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -61.392% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -60.729% |
| Senti Biosciences, Inc. | 52.57 Million USD | -363.227% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -9239.884% |
| Apollomics, Inc. | 14.15 Million USD | -1620.646% |
| PureTech Health plc | 125.58 Million USD | -93.914% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -3547.192% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -785.184% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -34.701% |
| Synaptogenix, Inc. | 5.52 Million USD | -4304.094% |
| ChromaDex Corporation | 26.5 Million USD | -818.677% |
| Beam Therapeutics Inc. | 478.38 Million USD | 49.095% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -13757.06% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | 10.564% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -48.448% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 59.017% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -14898.805% |
| Gritstone bio, Inc. | 125.91 Million USD | -93.397% |
| Mesoblast Limited | 188.79 Million USD | -28.986% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3065.093% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 29.938% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -76.722% |
| MediWound Ltd. | 27.18 Million USD | -795.733% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -87.023% |
| Fortress Biotech, Inc. | 165.93 Million USD | -46.755% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 39.313% |
| Achilles Therapeutics plc | 19.08 Million USD | -1175.858% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 39.641% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1221.699% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -4550.936% |
| Zai Lab Limited | 240.17 Million USD | -1.393% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -14605.495% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -156.132% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -135.22% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -251.729% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -9206.589% |
| FibroGen, Inc. | 585.72 Million USD | 58.424% |
| Celcuity Inc. | 51.45 Million USD | -373.319% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1300.926% |
| ContextLogic Inc. | 206 Million USD | -18.215% |
| GH Research PLC | 6.7 Million USD | -3534.129% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -240.687% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -2870.517% |
| ImmuCell Corporation | 18.81 Million USD | -1194.301% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -189.832% |
| Amarin Corporation plc | 279.58 Million USD | 12.899% |
| TG Therapeutics, Inc. | 169.08 Million USD | -44.024% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -1829.506% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1559.328% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 32.933% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -805.829% |
| Aptorum Group Limited | 5.25 Million USD | -4532.588% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 79.967% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 74.959% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -4624.905% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 49.095% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -6800.844% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -826.154% |
| Ardelyx, Inc. | 130.76 Million USD | -86.232% |
| Ainos, Inc. | 7.39 Million USD | -3193.422% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -357.922% |
| Prothena Corporation plc | 135.01 Million USD | -80.365% |
| HilleVax, Inc. | 78.9 Million USD | -208.612% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -0.173% |
| Celularity Inc. | 102.92 Million USD | -136.593% |
| Rallybio Corporation | 9.43 Million USD | -2480.786% |
| Cue Biopharma, Inc. | 24.44 Million USD | -896.208% |
| Omeros Corporation | 403.25 Million USD | 39.61% |
| Humacyte, Inc. | 114.67 Million USD | -112.356% |
| Immunocore Holdings plc | 228.15 Million USD | -6.734% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -4895.344% |
| Blueprint Medicines Corporation | 918.64 Million USD | 73.491% |
| IO Biotech, Inc. | 17.55 Million USD | -1287.121% |
| MEI Pharma, Inc. | 8.35 Million USD | -2814.698% |
| GT Biopharma, Inc. | 6.63 Million USD | -3571.385% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1295.387% |
| Summit Therapeutics Inc. | 125.25 Million USD | -94.419% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -12350.051% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -57.985% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -183.77% |
| Pulmatrix, Inc. | 15.96 Million USD | -1425.547% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1443.923% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -153.25% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -889.69% |
| Acelyrin, Inc. | 86.35 Million USD | -182.009% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | 2.905% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 79.885% |
| Vor Biopharma Inc. | 59.1 Million USD | -312.025% |
| Evogene Ltd. | 17.99 Million USD | -1253.658% |
| Replimune Group, Inc. | 113.21 Million USD | -115.1% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -238.325% |
| PDS Biotechnology Corporation | 33.25 Million USD | -632.199% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -34443.102% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 87.108% |
| AEON Biopharma, Inc. | 159.88 Million USD | -52.308% |
| BioLineRx Ltd. | 50.7 Million USD | -380.303% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -175.351% |
| Atai Life Sciences N.V. | 49.16 Million USD | -395.348% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1255.768% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2499.797% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -95.387% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4207.092% |
| MediciNova, Inc. | 3.89 Million USD | -6157.733% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1232.256% |
| MiMedx Group, Inc. | 96.33 Million USD | -152.801% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -16089.095% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 38.699% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 91.053% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1425.642% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -314.973% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1178.47% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -230.022% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2745.828% |
| Allakos Inc. | 74.79 Million USD | -225.596% |
| scPharmaceuticals Inc. | 57.26 Million USD | -325.286% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -982.276% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -112.106% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2180.134% |
| Precigen, Inc. | 41.64 Million USD | -484.773% |
| XOMA Corporation | 145.58 Million USD | -67.278% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -623.371% |
| Incyte Corporation | 1.59 Billion USD | 84.706% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -7449.291% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -254.169% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -293.904% |
| Seer, Inc. | 39.36 Million USD | -518.628% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3585.678% |
| CRISPR Therapeutics AG | 346.76 Million USD | 29.774% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -441.583% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -8385.122% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -2885.076% |
| Akari Therapeutics, Plc | 4.58 Million USD | -5212.456% |
| Novavax, Inc. | 2.57 Billion USD | 90.533% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -60191.7% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 24.157% |
| Entera Bio Ltd. | 1.37 Million USD | -17559.391% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -3481.221% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -254.076% |
| Chimerix, Inc. | 19.74 Million USD | -1133.34% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1193.546% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 49.954% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -421.027% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.819% |
| AnaptysBio, Inc. | 364.28 Million USD | 33.151% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -5452.78% |
| Portage Biotech Inc. | 4.45 Million USD | -5372.427% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -956.499% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -820.24% |
| OKYO Pharma Limited | 7.42 Million USD | -3181.607% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -5786.741% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -29351.005% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -30436.412% |
| AbCellera Biologics Inc. | 335.77 Million USD | 27.475% |
| Genprex, Inc. | 3.25 Million USD | -7383.326% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -797.979% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2180.134% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -67819.219% |
| Daré Bioscience, Inc. | 26.32 Million USD | -824.893% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -16764.474% |
| Bicycle Therapeutics plc | 224.41 Million USD | -8.516% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | 7.193% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1044.698% |
| Erasca, Inc. | 78.61 Million USD | -209.782% |
| bluebird bio, Inc. | 424.62 Million USD | 42.65% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -1942.635% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 87.116% |
| DBV Technologies S.A. | 42.8 Million USD | -468.979% |
| Fortress Biotech, Inc. | 165.93 Million USD | -46.755% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -90.563% |
| CorMedix Inc. | 11.91 Million USD | -1943.402% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 58.592% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2469.079% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -796.327% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -787.572% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -567.992% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 67.323% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -337.715% |
| Onconetix, Inc. | 23.18 Million USD | -950.534% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -5924.814% |
| Prime Medicine, Inc. | 60.78 Million USD | -300.663% |
| Adagene Inc. | 45.16 Million USD | -439.133% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | 7.893% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3428.258% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 65.09% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -58.972% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -111.831% |
| SciSparc Ltd. | 1.59 Million USD | -15167.9% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4276.058% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -185.296% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2008.424% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -222.564% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1273.266% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | 3.631% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -7819.839% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 93.988% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -23751.42% |
| 2seventy bio, Inc. | 310.12 Million USD | 21.476% |
| ADMA Biologics, Inc. | 193.97 Million USD | -25.543% |
| Clene Inc. | 38.95 Million USD | -525.203% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -573.965% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | 5.235% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -27.993% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -1899.423% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -22.792% |
| Absci Corporation | 58.3 Million USD | -317.678% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.574% |
| Surrozen, Inc. | 8.14 Million USD | -2889.847% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -235.584% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -575.365% |
| Cingulate Inc. | 10.36 Million USD | -2250.412% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -8755.382% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -6689.952% |
| Jaguar Health, Inc. | 45.86 Million USD | -430.944% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1751.886% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 23.228% |
| Kronos Bio, Inc. | 54.2 Million USD | -349.296% |
| Innoviva, Inc. | 568.55 Million USD | 57.168% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -417.66% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -7.358% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2105.887% |
| Soligenix, Inc. | 7.27 Million USD | -3247.439% |
| AlloVir, Inc. | 45.01 Million USD | -440.982% |
| Century Therapeutics, Inc. | 175.94 Million USD | -38.412% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -695.879% |
| Kura Oncology, Inc. | 51.66 Million USD | -371.377% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -3582.013% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2223.249% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -419.25% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1593.602% |
| Heron Therapeutics, Inc. | 256.47 Million USD | 5.051% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -814.063% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -8858.301% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -7323.88% |
| HCW Biologics Inc. | 15.05 Million USD | -1517.884% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -86.841% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | 8.013% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 70.411% |
| Lantern Pharma Inc. | 2.73 Million USD | -8788.732% |
| Histogen Inc. | 5.69 Million USD | -4174.583% |
| Surrozen, Inc. | 8.14 Million USD | -2889.847% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -473.333% |
| Kodiak Sciences Inc. | 213.59 Million USD | -14.014% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -1766.206% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2152.009% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -171.968% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1678.969% |
| Moderna, Inc. | 4.57 Billion USD | 94.674% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 90.646% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1621.254% |
| Immix Biopharma, Inc. | 3.72 Million USD | -6443.181% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -3563.102% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -43.158% |
| Exelixis, Inc. | 678.44 Million USD | 64.106% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -95.593% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -7.069% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3070.46% |
| Alkermes plc | 933.53 Million USD | 73.914% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1559.328% |
| Arcellx, Inc. | 339.75 Million USD | 28.323% |
| ESSA Pharma Inc. | 3.49 Million USD | -6867.612% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -4685.633% |
| Avid Bioservices, Inc. | 275.66 Million USD | 11.661% |
| Insmed Incorporated | 1.66 Billion USD | 85.345% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -1946.756% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | 0.821% |
| Moolec Science SA | 13.94 Million USD | -1646.266% |
| RenovoRx, Inc. | 4.46 Million USD | -5352.821% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -464.338% |
| Geron Corporation | 146.12 Million USD | -66.652% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -381.918% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -293.833% |
| Royalty Pharma plc | 6.29 Billion USD | 96.133% |
| OmniAb, Inc. | 87.4 Million USD | -178.63% |
| Alector, Inc. | 487.66 Million USD | 50.064% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -512.236% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -28.742% |
| Humacyte, Inc. | 114.67 Million USD | -112.356% |
| Structure Therapeutics Inc. | 29.05 Million USD | -738.26% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 61.349% |
| 89bio, Inc. | 59.96 Million USD | -306.122% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -20261.455% |
| Aura Biosciences, Inc. | 29.22 Million USD | -733.212% |
| Immunic, Inc. | 25.36 Million USD | -859.961% |
| Veracyte, Inc. | 93.71 Million USD | -159.844% |
| Genelux Corporation | 8.42 Million USD | -2792.197% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3451.969% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -37188.616% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4205.982% |
| Immunovant, Inc. | 48.95 Million USD | -397.443% |
| Vericel Corporation | 127.7 Million USD | -90.692% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 90.7% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -744.921% |
| XBiotech Inc. | 8.39 Million USD | -2800.119% |
| Agenus Inc. | 462.29 Million USD | 47.323% |
| Acasti Pharma Inc. | 11.55 Million USD | -2007.147% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3103.316% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -977.167% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -8858.301% |
| Theravance Biopharma, Inc. | 169 Million USD | -44.093% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 51.337% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -3894.8% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -3937.783% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -880.564% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -3565.859% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -49.413% |
| United Therapeutics Corporation | 1.18 Billion USD | 79.401% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -65469.988% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2745.828% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -77490.184% |
| Silo Pharma, Inc. | 1.56 Million USD | -15418.235% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -18133.72% |
| Pharming Group N.V. | 244.07 Million USD | 0.225% |
| XOMA Corporation | 145.58 Million USD | -67.278% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3585.678% |
| Bionomics Limited | 10.15 Million USD | -2297.182% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -962.816% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -407.107% |
| uniQure N.V. | 624.01 Million USD | 60.975% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -910.511% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1615.555% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -8056.38% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -739.3% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -43.094% |
| Pluri Inc. | 34.11 Million USD | -613.892% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -93353.142% |
| MeiraGTx Holdings plc | 319.99 Million USD | 23.897% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -217.335% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -1865.794% |
| CalciMedica, Inc. | 4.02 Million USD | -5945.755% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 12.337% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 60.576% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -18643.482% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -962.816% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -379.508% |
| Nutriband Inc. | 1.07 Million USD | -22471.018% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2190.257% |
| Compugen Ltd. | 55.77 Million USD | -336.617% |
| Roivant Sciences Ltd. | 773.95 Million USD | 68.535% |
| ProKidney Corp. | 29.21 Million USD | -733.526% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -37064.785% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -17768.762% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -62.936% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -681.717% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -120.457% |
| Benitec Biopharma Inc. | 4.96 Million USD | -4807.759% |
| GeoVax Labs, Inc. | 3.51 Million USD | -6818.501% |
| Biomea Fusion, Inc. | 30.69 Million USD | -693.493% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -680.497% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -659.538% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -178.366% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3386.87% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -54.282% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -621.122% |
| Imunon, Inc. | 8.53 Million USD | -2754.757% |
| BioAtla, Inc. | 48.98 Million USD | -397.128% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -86.459% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1613.141% |
| Zura Bio Limited | 21.29 Million USD | -1043.73% |
| aTyr Pharma, Inc. | 31.59 Million USD | -670.716% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -3.533% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -403.126% |
| Galecto, Inc. | 5.89 Million USD | -4030.309% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1273.266% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 85.236% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -78.642% |
| PolyPid Ltd. | 17.46 Million USD | -1294.109% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -116.659% |
| Forte Biosciences, Inc. | 3.66 Million USD | -6542.744% |
| Xencor, Inc. | 283.55 Million USD | 14.119% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -6381.632% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -60191.7% |
| Instil Bio, Inc. | 99.8 Million USD | -144.009% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -16089.095% |
| OncoCyte Corporation | 49.29 Million USD | -393.982% |
| Elevation Oncology, Inc. | 34.28 Million USD | -610.352% |
| Purple Biotech Ltd. | 10 Million USD | -2334.013% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4108.832% |
| MacroGenics, Inc. | 154.2 Million USD | -57.92% |
| Verona Pharma plc | 58.84 Million USD | -313.866% |
| Tharimmune, Inc. | 1.81 Million USD | -13316.905% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1033.139% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1582.602% |
| Aditxt, Inc. | 28.53 Million USD | -753.522% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -118115.049% |
| Savara Inc. | 37.19 Million USD | -554.773% |
| Curis, Inc. | 57.61 Million USD | -322.695% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -521.235% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1069.715% |
| BeiGene, Ltd. | 2.23 Billion USD | 89.098% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -37064.785% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3381.387% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -1812.084% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1326.614% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -66.946% |
| Adicet Bio, Inc. | 37.12 Million USD | -556.043% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -134665.718% |
| Quantum-Si incorporated | 26.63 Million USD | -814.434% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -7904.206% |
| Generation Bio Co. | 171.63 Million USD | -41.888% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -482.159% |
| Invivyd, Inc. | 51.71 Million USD | -370.913% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -164.765% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -3643.484% |
| Moolec Science SA | 13.94 Million USD | -1646.266% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -387.729% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2391.539% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -1896.941% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -360.86% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 34.157% |
| Evaxion Biotech A/S | 17.61 Million USD | -1282.281% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -51.323% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1027.682% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -553.017% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -880.011% |
| Clearmind Medicine Inc. | 3.61 Million USD | -6645.775% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -794.384% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -189.819% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -969.973% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1113.308% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -544.036% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -153.019% |
| ImmunityBio, Inc. | 1.09 Billion USD | 77.666% |
| Korro Bio, Inc. | 51.75 Million USD | -370.558% |
| Kineta, Inc. | 7.22 Million USD | -3271.961% |
| BioVie Inc. | 9.7 Million USD | -2409.995% |
| Codexis, Inc. | 49.94 Million USD | -387.573% |
| Celularity Inc. | 102.92 Million USD | -136.593% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -70446.707% |
| Cibus, Inc. | 206.11 Million USD | -18.148% |
| Annexon, Inc. | 47.11 Million USD | -416.836% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -152.691% |
| Eyenovia, Inc. | 19.78 Million USD | -1131.14% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -37.517% |
| NeurAxis, Inc. | 1.91 Million USD | -12631.638% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2446.513% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -2820.991% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -9798.174% |
| Notable Labs, Ltd. | 4.42 Million USD | -5400.858% |
| IN8bio, Inc. | 8.77 Million USD | -2676.14% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -7747.986% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -229.704% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1726.468% |
| Liquidia Corporation | 73.13 Million USD | -232.964% |
| Mustang Bio, Inc. | 17.61 Million USD | -1282.161% |
| Quantum-Si incorporated | 26.63 Million USD | -814.434% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -534.455% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1582.602% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -9929.778% |
| 180 Life Sciences Corp. | 5.38 Million USD | -4420.393% |
| Vaxcyte, Inc. | 167.44 Million USD | -45.431% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -560.366% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -134665.718% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -223.946% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -932.403% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -969.973% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -950.393% |
| PepGen Inc. | 34.63 Million USD | -603.194% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -1905.295% |
| Solid Biosciences Inc. | 38.45 Million USD | -533.218% |
| Palisade Bio, Inc. | 2.73 Million USD | -8790.946% |
| Nutriband Inc. | 1.07 Million USD | -22471.018% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3070.46% |
| Immuneering Corporation | 12 Million USD | -1927.946% |
| Belite Bio, Inc | 4.21 Million USD | -5683.021% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1578.196% |
| GeoVax Labs, Inc. | 3.51 Million USD | -6818.501% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -4535.884% |
| Altimmune, Inc. | 16.54 Million USD | -1372.239% |
| Peak Bio, Inc. | 20.75 Million USD | -1073.415% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1300.926% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2204.343% |
| Neurogene Inc. | 36.54 Million USD | -566.292% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 38.806% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -9860.041% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -411.066% |
| Sesen Bio, Inc. | 30.98 Million USD | -685.964% |
| argenx SE | 444.95 Million USD | 45.27% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -223.946% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2211.561% |
| Immunome, Inc. | 28.65 Million USD | -749.756% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -10291.405% |
| Design Therapeutics, Inc. | 11.95 Million USD | -1936.827% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -525.573% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -838.034% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -24.413% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -26.797% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -338.028% |
| Athira Pharma, Inc. | 30.05 Million USD | -710.204% |
| XOMA Corporation | 145.58 Million USD | -67.278% |
| Merus N.V. | 102.15 Million USD | -138.395% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -156.017% |
| Rezolute, Inc. | 11.73 Million USD | -1975.362% |
| Clene Inc. | 38.95 Million USD | -525.203% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -8452.529% |
| BeyondSpring Inc. | 48.26 Million USD | -404.512% |
| Synlogic, Inc. | 32.89 Million USD | -640.304% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1566.482% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -14803.488% |
| Peak Bio, Inc. | 20.75 Million USD | -1073.415% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -283.749% |
| Krystal Biotech, Inc. | 39.71 Million USD | -513.192% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 35.344% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -144.577% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -56176.489% |
| MannKind Corporation | 721.36 Million USD | 66.241% |
| Ikena Oncology, Inc. | 22.33 Million USD | -990.32% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -11574.161% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -137.375% |
| Gossamer Bio, Inc. | 249.14 Million USD | 2.257% |
| CohBar, Inc. | 1.03 Million USD | -23459.796% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2178.258% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1178.47% |
| Legend Biotech Corporation | 589.93 Million USD | 58.72% |
| Mural Oncology plc | 37.92 Million USD | -542.067% |
| Disc Medicine, Inc. | 22.87 Million USD | -964.581% |
| Champions Oncology, Inc. | 28.03 Million USD | -768.639% |
| REGENXBIO Inc. | 262.22 Million USD | 7.133% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -7149.106% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -1842.899% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1713.057% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1048.423% |
| Vaxart, Inc. | 34.02 Million USD | -615.718% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1094.369% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -753.512% |
| Cellectis S.A. | 249.57 Million USD | 2.425% |
| Longeveron Inc. | 5.33 Million USD | -4462.919% |
| Repare Therapeutics Inc. | 41.81 Million USD | -482.326% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 89.875% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -303.397% |
| Revolution Medicines, Inc. | 262.39 Million USD | 7.193% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -11457.807% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -2723.128% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -1963.579% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1634.124% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -11221.385% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 95.271% |
| Denali Therapeutics Inc. | 122.96 Million USD | -98.046% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4276.058% |
| Veru Inc. | 32.81 Million USD | -642.161% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3445.247% |
| Cingulate Inc. | 10.36 Million USD | -2250.412% |
| Passage Bio, Inc. | 39.26 Million USD | -520.251% |
| Context Therapeutics Inc. | 4.19 Million USD | -5709.627% |
| Exicure, Inc. | 8.54 Million USD | -2748.555% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -725.278% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2222.363% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1004.864% |
| Nuvalent, Inc. | 31.82 Million USD | -665.242% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -3727.999% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -286.41% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1252.906% |
| OmniAb, Inc. | 87.4 Million USD | -178.63% |
| Anew Medical, Inc. | 8.24 Million USD | -2854.731% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -536.011% |
| Lipocine Inc. | 2.63 Million USD | -9153.698% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -826.93% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -505.598% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -814.063% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -182.66% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -4408.85% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -194.298% |
| Ocugen, Inc. | 23.98 Million USD | -915.398% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -424.755% |
| Q32 Bio Inc. | 233.12 Million USD | -4.459% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2586.113% |
| Alumis Inc. Common Stock | 53.5 Million USD | -355.166% |
| Equillium, Inc. | 27.95 Million USD | -771.063% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -17.876% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4228.017% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -3870.72% |
| Dominari Holdings Inc. | 4.63 Million USD | -5154.002% |
| Edesa Biotech, Inc. | 1.84 Million USD | -13123.181% |
| vTv Therapeutics Inc. | 29.56 Million USD | -723.631% |
| Bio-Techne Corporation | 744.34 Million USD | 67.283% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -93.12% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 29.302% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -500.18% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -740.981% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -163.667% |
| Nkarta, Inc. | 105.6 Million USD | -130.609% |
| BioCardia, Inc. | 4.59 Million USD | -5205.512% |
| Iterum Therapeutics plc | 32.66 Million USD | -645.585% |